You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Caribe Holdings Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CARIBE HOLDINGS, and what generic and branded alternatives to CARIBE HOLDINGS drugs are available?

CARIBE HOLDINGS has two approved drugs.

Summary for Caribe Holdings
US Patents:0
Patent Litigation for Caribe Holdings: See patent lawsuits for Caribe Holdings

Drugs and US Patents for Caribe Holdings

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Caribe Holdings DOXYCYCLINE HYCLATE doxycycline hyclate TABLET;ORAL 062269-002 Nov 8, 1982 AB RX No Yes   Start Trial   Start Trial
Caribe Holdings DOXYCYCLINE HYCLATE doxycycline hyclate TABLET;ORAL 062269-003 Oct 5, 1983 RX No No   Start Trial   Start Trial
Caribe Holdings GEMFIBROZIL gemfibrozil TABLET;ORAL 078012-001 Mar 26, 2007 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.